Patent ID: 9238651
Filing Date: 2016-01-19
CPC Classification: A61K,A61N,A61P,C07D

Claim Text:
1. A method for the treatment of a tumour, tumour growth, or tumour metastases, where the tumour originates from a tumour of the squamous epithelium, of the bladder, of the kidneys, of the head and neck, of the oesophagus, of the cervix, of the thyroid, of the intestine, of the liver, of the brain, of the prostate, of the urogenital tract, of the lymphatic system, of the stomach, of the larynx or of the lung or originates from monocytic leukaemia, lung adenocarcinoma, small-cell lung carcinoma, pancreatic cancer, colon carcinoma, glioblastoma or breast carcinoma, comprising administering to a subject in need thereof an effective amount of one of the following compounds or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof.